Matthew Gline

Matthew Gline serves as Chief Executive Officer at Roivant Sciences. Roivant Sciences operates in the biotechnology sector with approximately 260.0 employees. The company is headquartered in New York, New York. Roivant Sciences generates annual revenue of 122590000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 3 executives at Roivant Sciences.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Route 53 Microsoft Office 365 Amazon AWS Rackspace MailGun Mimecast Outlook Marketo ADP WP Engine Atlassian Cloud Pantheon Greenhouse.io Google Font API Nginx Mobile Friendly SoundCloud Google Tag Manager Varnish Vimeo New Relic Typekit Remote AI Android Laravel React Native

biotechnology: pharmaceutical preparations health care transformative medicines fda approvals phase 3 trials immuno-dermatology therapeutics clinical development drug discovery biopharmaceuticals vant model agile companies capital allocation immunology autoimmune diseases strategic partnerships dermatology treatments rvt-3101 ulcerative colitis chronic inflammatory diseases molecular glues ai in drug discovery patient outcomes investigational drugs topical therapies clinical trials biomarker-driven innovative therapeutics pharmaceutical acquisitions biotech industry patient care health equity community health drug commercialization regulatory submissions biologics lead optimization preclinical studies healthcare technology stakeholder engagement market access venture capital governance diversity in pharma scientific innovation disruptive healthcare sustainability digital therapeutics global health solutions research & development healthcare innovation drug development pharmaceutical technology agile subsidiaries vants patient-centric healthcare technology platforms data sharing computational drug discovery rare diseases oncology neuroscience transformative therapies clinical efficacy social impact diverse pipeline rapid commercialization transparency market potential unmet medical needs healthcare solutions nimble execution collaborative science ethical standards diversity & inclusion health wellness & fitness hospital & health care environmental services renewables & environment biotechnology

SG

Stephanie Griffin COO, Roivant Platforms at Roivant Sciences

ZK

Zachary Kanter Chief Business Officer at Roivant Sciences

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

How can I contact Matthew Gline?

Matthew Gline's verified email address is available on MessageCEO. They currently work at Roivant Sciences. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Matthew Gline lead?

Matthew Gline is Chief Executive Officer at Roivant Sciences, a company in the biotechnology sector with 260.0 employees. The company is based in New York, New York.

What industry is Matthew Gline in?

Matthew Gline works in the biotechnology industry as Chief Executive Officer at Roivant Sciences. MessageCEO provides verified contact information for executives across all major industries.

Is Matthew Gline's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Matthew Gline's profile is kept up-to-date with the latest available information.

Last updated: April 7, 2026